These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 22238306)
1. The viral protein Tat can inhibit the establishment of HIV-1 latency. Donahue DA; Kuhl BD; Sloan RD; Wainberg MA J Virol; 2012 Mar; 86(6):3253-63. PubMed ID: 22238306 [TBL] [Abstract][Full Text] [Related]
2. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat. Chakraborty S; Kabi M; Ranga U J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338 [TBL] [Abstract][Full Text] [Related]
3. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218 [TBL] [Abstract][Full Text] [Related]
4. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein. Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D mBio; 2016 Jul; 7(4):. PubMed ID: 27381288 [TBL] [Abstract][Full Text] [Related]
5. Probabilistic control of HIV latency and transactivation by the Tat gene circuit. Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316 [TBL] [Abstract][Full Text] [Related]
6. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A mBio; 2018 Nov; 9(6):. PubMed ID: 30425153 [TBL] [Abstract][Full Text] [Related]
7. Lost in transcription: molecular mechanisms that control HIV latency. Taube R; Peterlin M Viruses; 2013 Mar; 5(3):902-27. PubMed ID: 23518577 [TBL] [Abstract][Full Text] [Related]
8. HIV latency reversing agents act through Tat post translational modifications. Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762 [TBL] [Abstract][Full Text] [Related]
9. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency. Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L mBio; 2018 Nov; 9(6):. PubMed ID: 30401776 [TBL] [Abstract][Full Text] [Related]
10. The Molecular Basis for Human Immunodeficiency Virus Latency. Mbonye U; Karn J Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973 [TBL] [Abstract][Full Text] [Related]
11. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583 [TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression. Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W J Virol; 2018 May; 92(9):. PubMed ID: 29491162 [TBL] [Abstract][Full Text] [Related]
13. Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses. Donahue DA; Bastarache SM; Sloan RD; Wainberg MA J Virol; 2013 Sep; 87(17):9620-32. PubMed ID: 23804632 [TBL] [Abstract][Full Text] [Related]
14. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency. Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure. Mbonye U; Karn J Virology; 2014 Apr; 454-455():328-39. PubMed ID: 24565118 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant. Balboni PG; Bozzini R; Zucchini S; Marconi PC; Grossi MP; Caputo A; Manservigi R; Barbanti-Brodano G J Med Virol; 1993 Dec; 41(4):289-95. PubMed ID: 8106862 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes. Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458 [TBL] [Abstract][Full Text] [Related]
18. Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression. Liu Y; Niu Y; Li L; Timani KA; He VL; Sanburns C; Xie J; He JJ J Neurovirol; 2019 Aug; 25(4):508-519. PubMed ID: 31020497 [TBL] [Abstract][Full Text] [Related]
19. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter. Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233 [TBL] [Abstract][Full Text] [Related]
20. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells. Macías D; Oya R; Saniger L; Martín F; Luque F Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]